STOCK TITAN

Trueblue SEC Filings

TBI NYSE

Welcome to our dedicated page for Trueblue SEC filings (Ticker: TBI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The TrueBlue, Inc. (NYSE: TBI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. As a public provider of specialized workforce solutions and staffing services, TrueBlue files a range of documents with the U.S. Securities and Exchange Commission that shed light on its financial performance, segment trends, governance, and strategic priorities.

Investors can review current reports on Form 8-K, where TrueBlue discloses material events such as quarterly earnings results, changes in directors and executive officers, and other significant developments. For example, recent 8-K filings describe third quarter 2025 financial results, the appointment of new independent directors to the board, and leadership changes at PeopleReady, as well as the appointment of a new Senior Vice President and Chief Accounting Officer.

Annual reports on Form 10-K and quarterly reports on Form 10-Q (referenced in the company’s proxy and earnings materials) provide more detailed information on segment revenue and profit for PeopleReady, PeopleManagement, and PeopleSolutions, along with discussions of non-GAAP measures such as Adjusted net income and Adjusted EBITDA. These filings also outline risk factors, accounting policies, and other disclosures relevant to a staffing and workforce management company.

Filings related to proxy statements on Schedule 14A are particularly important for understanding TrueBlue’s corporate governance and shareholder dynamics. The company has indicated in multiple communications that it intends to file proxy statements and associated proxy cards in connection with its annual meetings, including discussions of board refreshment, director biographies, compensation, and security ownership of certain beneficial owners and management. Some 8-Ks are also marked as soliciting material under Rule 14a-12, reflecting their role in proxy-related communications.

On Stock Titan, these documents are updated in near real time as they are posted to EDGAR. AI-powered summaries highlight key points from lengthy filings, helping users quickly identify information on segment performance, board and executive changes, and other material items. Users can also monitor Form 4 filings referenced in company materials for insights into changes in ownership by directors and executive officers, providing additional context on insider activity.

By combining direct access to TrueBlue’s SEC filings with AI-generated explanations, this page helps investors, analysts, and other stakeholders navigate complex regulatory documents and better understand how financial results, governance decisions, and strategic initiatives are reflected in the company’s official disclosures.

Rhea-AI Summary

Kreidler Robert C. reported acquisition or exercise transactions in this Form 4 filing.

TrueBlue, Inc. director Robert C. Kreidler reported an equity award of 27,566 shares of common stock in the form of restricted stock units. These units will vest in full one year from the grant date and will be settled on a one-for-one basis in common shares.

Delivery of the vested shares to Kreidler will occur 90 days after his separation from service on the Board of Directors. Following this award, his directly held and deferred holdings total 85,381 shares, including 71,664 shares deferred under the company’s Equity Retainer and Deferred Compensation Plan for Non-Employee Directors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Jones Kim Harris reported acquisition or exercise transactions in this Form 4 filing.

TrueBlue, Inc. director Kim Harris Jones reported an equity award of 29,607 shares of common stock in the form of restricted stock units. These units will vest in full one year from the grant date and will be settled on a one-for-one basis into common shares.

After this grant, her directly held and deferred holdings total 100,060 shares, including 94,719 shares deferred under TrueBlue’s Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. Vested shares from this award will be delivered 90 days after her separation from the Board.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TrueBlue, Inc. director Colleen B. Brown reported an equity award of 29,097 shares of Common Stock at a stated price of $0.00 per share. A footnote explains this represents a grant of restricted stock units that will convert into shares on a one-for-one basis and vest in full one year from the grant date. Following this award, her directly held Common Stock balance is 89,112 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

TrueBlue, Inc. outlines its role as a specialized workforce solutions provider and key risks facing the business. In fiscal 2025, the company connected approximately 291,000 people with work and served about 53,000 clients across construction, logistics, retail, hospitality, healthcare and other sectors.

Operations are organized into three segments: PeopleReady for on-demand and skilled trades staffing, PeopleManagement for on‑site industrial and driver solutions, and PeopleSolutions for recruitment process outsourcing, managed service provider programs and healthcare staffing. Strategy for fiscal 2026 focuses on strengthening sales, expanding in high‑growth and less cyclical end markets (including healthcare and skilled trades), and accelerating technology such as JobStack, Stafftrack and the Affinix platform.

The filing highlights extensive risk factors, including economic cyclicality, technology disruption and AI, workers’ compensation costs, client concentration, integration of acquisitions such as Healthcare Staffing Professionals, Inc., regulatory and tax changes, cybersecurity and data privacy exposures, and the need to attract and retain employees and contingent associates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.5%
Tags
annual report
-
Rhea-AI Summary

TrueBlue, Inc. reported fourth-quarter 2025 revenue of $418 million, an 8% increase driven by 5% organic growth and contributions from the HSP acquisition. Despite higher sales, the company posted a net loss of $31.5 million, widened by an $18.4 million non-cash impairment tied to a Chicago support center sublease and lower gross margin from reduced workers’ compensation benefits and mix shifts toward renewable energy work.

Adjusted EBITDA was $2.4 million versus $8.9 million a year earlier, while SG&A fell 11% to $95 million as cost actions took hold. For full-year 2025, revenue reached $1.616 billion, up 3%, with net loss improving to $48.0 million from $125.7 million and adjusted net loss at $20.4 million. The company ended the year with $25 million in cash, $66 million of debt, total liquidity of $92 million, and increased borrowing capacity following a credit facility amendment. Management guided first-quarter 2026 revenue to $381–$406 million, expecting gross margin pressure from prior-year reserve benefits not repeating but further SG&A reductions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.5%
Tags
current report
-
Rhea-AI Summary

Charles Schwab Investment Management Inc. filed an amended Schedule 13G reporting a passive ownership stake in TrueBlue, Inc. common stock. It reports beneficial ownership of 2,012,217 shares, representing 6.72% of the class as of 12/31/2025.

The firm has sole voting and sole dispositive power over all reported shares, with no shared voting or dispositive authority. It certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of TrueBlue.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

TrueBlue, Inc. executive Richard P. Betori, EVP and President of PeopleScout, reported a small stock disposition on a Form 4. On February 4, 2026, he disposed of 379 shares of TrueBlue common stock at $5.51 per share under transaction code F.

Following this transaction, Betori directly beneficially owns 101,401 shares of TrueBlue common stock. The filing reflects a single, non-derivative transaction and shows no derivative securities activity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TrueBlue, Inc. CEO and President Taryn R. Owen, who also serves as a director, reported an insider equity transaction dated February 3, 2026 involving 5,250 shares of common stock at $5.50 per share, leaving her with 403,259 shares beneficially owned directly.

A footnote explains that her reported beneficial ownership was also reduced by 2,515 shares due to an administrative correction to the number of shares previously withheld to cover tax obligations for five vesting events reported on filings dated February 7, 2023 and February 9, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TrueBlue, Inc. executive Richard P. Betori reported a small share disposition. On February 3, 2026, he disposed of 515 shares of Common Stock at $5.50 per share under transaction code F. After this transaction, he directly beneficially owned 101,780 Common Stock shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

TrueBlue, Inc. executive Carl Schweihs reported a small share disposition. On February 3, 2026, he disposed of 1,584 shares of TrueBlue common stock at $5.50 per share, leaving him with 170,036 shares beneficially owned directly.

This remaining total includes approximately 9,560 shares acquired through the TrueBlue Employee Stock Purchase Plan, showing that Schweihs continues to hold a significant personal stake in the company despite the modest transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Trueblue (TBI)?

The current stock price of Trueblue (TBI) is $3.58 as of March 20, 2026.

What is the market cap of Trueblue (TBI)?

The market cap of Trueblue (TBI) is approximately 110.3M.

TBI Rankings

TBI Stock Data

110.33M
27.61M
Staffing & Employment Services
Services-help Supply Services
Link
United States
TACOMA

TBI RSS Feed